Research programme: T cell receptor cell therapies - ElevateBio
Latest Information Update: 20 May 2024
At a glance
- Originator ElevateBio
- Class Gene therapies; Immunotherapies; T lymphocyte cell therapies
- Mechanism of Action T lymphocyte replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Unspecified